US Stock MarketDetailed Quotes

RCUS Arcus Biosciences

Watchlist
  • 15.500
  • +0.820+5.59%
Close Apr 23 16:00 ET
1.41BMarket Cap-3734P/E (TTM)

Arcus Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
4.46%117M
-8.82%31M
-3.03%32M
7.41%29M
38.89%25M
-70.76%112M
-90.41%34M
248.80%33M
185.38%27M
90.25%18M
Operating revenue
4.46%117M
-8.82%31M
-3.03%32M
7.41%29M
38.89%25M
-70.76%112M
-90.41%34M
248.80%33M
185.38%27M
90.25%18M
Cost of revenue
Gross profit
Operating expense
16.58%457M
12.96%122M
8.74%112M
16.67%112M
30.59%111M
19.15%392M
46.74%108M
17.58%103M
12.15%96M
3.40%85M
Selling and administrative expenses
12.50%117M
3.57%29M
15.38%30M
7.69%28M
25.00%30M
44.44%104M
21.69%28M
59.09%26M
54.52%26M
51.70%24M
-General and administrative expense
12.50%117M
3.57%29M
15.38%30M
7.69%28M
25.00%30M
44.44%104M
21.69%28M
59.09%26M
54.52%26M
51.70%24M
Research and development costs
18.06%340M
16.25%93M
6.49%82M
20.00%84M
32.79%81M
12.06%288M
58.14%80M
8.06%77M
1.79%70M
-8.11%61M
Operating profit
-21.43%-340M
-22.97%-91M
-14.29%-80M
-20.29%-83M
-28.36%-86M
-618.52%-280M
-126.33%-74M
10.41%-70M
9.37%-69M
7.90%-67M
Net non-operating interest income expense
178.57%39M
57.14%11M
120.00%11M
350.00%9M
8M
1,300.00%14M
1,248.75%7M
3,005.59%5M
1,104.82%2M
0
Non-operating interest income
156.25%41M
37.50%11M
140.00%12M
200.00%9M
--9M
1,500.00%16M
1,441.43%8M
3,005.59%5M
1,707.23%3M
--0
Non-operating interest expense
0.00%2M
--0
--1M
--0
--1M
--2M
--1M
--0
--1M
--0
Other net income (expense)
Income before tax
-13.16%-301M
-19.40%-80M
-6.15%-69M
-10.45%-74M
-16.42%-78M
-583.64%-266M
-123.80%-67M
16.64%-65M
11.81%-67M
7.70%-67M
Income tax
500.00%6M
1M
2M
1M
100.00%2M
-50.00%1M
0
0
0
1M
Net income
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
11.81%-67M
6.33%-68M
Net income continuous Operations
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
11.81%-67M
6.33%-68M
Minority interest income
Net income attributable to the parent company
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
11.81%-67M
6.33%-68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.98%-307M
-20.90%-81M
-9.23%-71M
-11.94%-75M
-17.65%-80M
-603.77%-267M
-123.97%-67M
16.64%-65M
11.81%-67M
6.33%-68M
Basic earnings per share
-11.86%-4.15
-16.13%-1.08
-4.44%-0.94
-11.83%-1.04
-13.54%-1.09
-588.16%-3.71
-123.43%-0.93
18.92%-0.9
14.68%-0.93
11.11%-0.96
Diluted earnings per share
-11.86%-4.15
-16.13%-1.08
-4.44%-0.94
-11.83%-1.04
-13.54%-1.09
-622.54%-3.71
-125.07%-0.93
18.92%-0.9
14.68%-0.93
11.11%-0.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 4.46%117M-8.82%31M-3.03%32M7.41%29M38.89%25M-70.76%112M-90.41%34M248.80%33M185.38%27M90.25%18M
Operating revenue 4.46%117M-8.82%31M-3.03%32M7.41%29M38.89%25M-70.76%112M-90.41%34M248.80%33M185.38%27M90.25%18M
Cost of revenue
Gross profit
Operating expense 16.58%457M12.96%122M8.74%112M16.67%112M30.59%111M19.15%392M46.74%108M17.58%103M12.15%96M3.40%85M
Selling and administrative expenses 12.50%117M3.57%29M15.38%30M7.69%28M25.00%30M44.44%104M21.69%28M59.09%26M54.52%26M51.70%24M
-General and administrative expense 12.50%117M3.57%29M15.38%30M7.69%28M25.00%30M44.44%104M21.69%28M59.09%26M54.52%26M51.70%24M
Research and development costs 18.06%340M16.25%93M6.49%82M20.00%84M32.79%81M12.06%288M58.14%80M8.06%77M1.79%70M-8.11%61M
Operating profit -21.43%-340M-22.97%-91M-14.29%-80M-20.29%-83M-28.36%-86M-618.52%-280M-126.33%-74M10.41%-70M9.37%-69M7.90%-67M
Net non-operating interest income expense 178.57%39M57.14%11M120.00%11M350.00%9M8M1,300.00%14M1,248.75%7M3,005.59%5M1,104.82%2M0
Non-operating interest income 156.25%41M37.50%11M140.00%12M200.00%9M--9M1,500.00%16M1,441.43%8M3,005.59%5M1,707.23%3M--0
Non-operating interest expense 0.00%2M--0--1M--0--1M--2M--1M--0--1M--0
Other net income (expense)
Income before tax -13.16%-301M-19.40%-80M-6.15%-69M-10.45%-74M-16.42%-78M-583.64%-266M-123.80%-67M16.64%-65M11.81%-67M7.70%-67M
Income tax 500.00%6M1M2M1M100.00%2M-50.00%1M0001M
Net income -14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M11.81%-67M6.33%-68M
Net income continuous Operations -14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M11.81%-67M6.33%-68M
Minority interest income
Net income attributable to the parent company -14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M11.81%-67M6.33%-68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.98%-307M-20.90%-81M-9.23%-71M-11.94%-75M-17.65%-80M-603.77%-267M-123.97%-67M16.64%-65M11.81%-67M6.33%-68M
Basic earnings per share -11.86%-4.15-16.13%-1.08-4.44%-0.94-11.83%-1.04-13.54%-1.09-588.16%-3.71-123.43%-0.9318.92%-0.914.68%-0.9311.11%-0.96
Diluted earnings per share -11.86%-4.15-16.13%-1.08-4.44%-0.94-11.83%-1.04-13.54%-1.09-622.54%-3.71-125.07%-0.9318.92%-0.914.68%-0.9311.11%-0.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg